Additional evidence for ATM involvement in outcome of sepsis includes two key findings showing that (i) the PARP1 inhibitor Olaparib confers beneficial effects to mice subjected to CLP sepsis [127], and (ii) anthracyclines trigger ATM activation, which is associated with 80% improvement in septic mouse survival [128]. Here, PARP1 is linked to Sepsis.